Free Publications

Search for clinical trials returned 500 results

Glossary Results

Clinical trials

Careful studies done by doctors to test new drugs or treatments, or new uses for approved drugs or treatments. The goal of clinical trials for blood cancers is to improve treatment and quality of life and to find cures.

Epigenetic Change

Any change that alters gene activity without changing the DNA sequence. Many types of epigenetic changes have been identified. While epigenetic changes are natural and essential to many of the body's functions, certain epigenetic changes can cause major adverse health effects, including cancer. Drugs that target specific epigenetic changes - for example, the histone deacetylase (HDAC) inhibitor vorinostat (Zolinza® )- are approved to treat some blood cancers and are being studied in clinical trials for treatment of other blood cancers

Making Informed Decisions: Clinical Trials- Malvern, PA

Learn how clinical trials really work: how they are developed, benefits and risks, sorting out the myths from the facts, and determining if a clinical trial is the right decision for you. Carolyn Vachani, RN, MSN, AOCN, from Penn Medicine's OncoLink will speak on these aspects and more. Complimentary breakfast will be provided. Support for this program has been provided by Celgene and Takeda Oncology. 

Read more

Clinical Trials

Taking part in a clinical trial may be a treatment choice for some hairy cell leukemia patients. Clinical trials are under way to develop treatments that increase the remission rate of hairy cell leukemia or cure the disease. Today's standard treatments for cancer are based on earlier clinical trials. The Leukemia & Lymphoma Society continues to invest funds in hairy cell leukemia research. Clinical trials can involve new drugs, new combinations of drugs or approved drugs b ...

  • Photo
Read more

Clinical Trials

Advances in cancer treatment depend on clinical trials of new therapies or new therapy combination. Researchers can design a clinical trial to test new treatment that improves response or quality of life for patients at any treatment stage. Talk to your doctor about whether treatment in a clinical trial is a good option for you.   How to Gather Information Make any treatment decisions in consultation with your doctor. You may also want to speak with one or more specialists ...

  • Photo
Read more

Clinical Trials

Taking part in a clinical trial may be a good treatment choice for people with chronic myelomonocytic leukemia (CMML). Clinical trials are under way to help improve treatment, extend survival and improve the quality of life for CMML patients. Today's standard treatments for cancer are based on earlier clinical trials. The Leukemia & Lymphoma Society continues to invest funds in CMML research. Clinical trials can involve new drugs, new combinations of drugs or approved drugs ...

  • Photo
Read more

Clinical Trials

Taking part in a clinical trial may be the best treatment choice for some acute lymphoblastic leukemia (ALL) patients. Clinical trials are under way for patients at every treatment stage and for patients in remission. Today's standard treatments for cancer are based on earlier clinical trials. The Leukemia & Lymphoma Society continues to invest funds in ALL research. Click here to read more about clinical trials. Current ALL Research and Clinical Trials New approaches ...

  • Photo
Read more

Pages

Glossary Results

Clinical trials

Careful studies done by doctors to test new drugs or treatments, or new uses for approved drugs or treatments. The goal of clinical trials for blood cancers is to improve treatment and quality of life and to find cures.

Epigenetic Change

Any change that alters gene activity without changing the DNA sequence. Many types of epigenetic changes have been identified. While epigenetic changes are natural and essential to many of the body's functions, certain epigenetic changes can cause major adverse health effects, including cancer. Drugs that target specific epigenetic changes - for example, the histone deacetylase (HDAC) inhibitor vorinostat (Zolinza® )- are approved to treat some blood cancers and are being studied in clinical trials for treatment of other blood cancers